Wei, X., Yang, J., Adair, S. J., Ozturk, H., Kuscu, C., Lee, K. Y., . . . Adli, M. (2020). Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells. Proc Natl Acad Sci U S A.
Chicago-tyylinen lähdeviittausWei, Xiaolong, et al. "Targeted CRISPR Screening Identifies PRMT5 As Synthetic Lethality Combinatorial Target With Gemcitabine in Pancreatic Cancer Cells." Proc Natl Acad Sci U S A 2020.
MLA-viiteWei, Xiaolong, et al. "Targeted CRISPR Screening Identifies PRMT5 As Synthetic Lethality Combinatorial Target With Gemcitabine in Pancreatic Cancer Cells." Proc Natl Acad Sci U S A 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.